Analysts think IVF stock price could increase by 192%
May 11, 2025, 11:25 AM
-27.92%
What does IVF do
INVO BioScience, based in Lakewood Ranch, Florida, specializes in assisted reproductive technology and offers the INVOcell device for in vivo fertilization, with three operational centers in North America. The company went public on November 11, 2008, and aims to make fertility care more accessible and affordable.
2 analysts think IVF stock price will increase by 192.12%. The current median analyst target is $6.12 compared to a current stock price of $2.10. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
